Skip to main content
. Author manuscript; available in PMC: 2015 Feb 25.
Published in final edited form as: Inflamm Bowel Dis. 2014 Jul;20(7):1259–1287. doi: 10.1097/MIB.0000000000000047

Table 3.

Affinities of orthosteric adenosine receptor ligands that are commonly used as pharmacological probes. Affinity is shown at the human adenosine receptors, unless noted. Structures are shown in Figures 1A and 2A.

No. Compound Affinity, pKia
A1 A2A A2Bb A3
Adenosine receptor agonists
1 adenosineb ~7
7.14 (r)
6.49
6.82 (r)
4.82
5.29 (r)
6.54
5.19 (r)
A1-selective
2 R-PIA 8.69
8.92 (r)
6.66 (r) 3.82 7.48
6.80 (r)
3 CPA 8.64 6.10 4.73 7.14
4 CCPA 9.08
8.89 (r)
5.64
6.02 (r)
4.73 7.42
6.63 (r)
5 5′-Cl-5′-deoxy-ENBA 9.29 5.89 5.87 5,56
A2A-selective
6 CGS21680 6.54
5.74 (r)
7.57
7.72 (r)
<5
<5 (r)
7.17
6.23 (r)
7 UK432,097 ND 8.4 ND ND
A2B-selective
8 BAY 60-6583 <5b <5b 8–8.5 <5b
A3-selective
9 IB-MECA (CF101) 7.29 5.54 4.96 8.74
10 Cl-IB-MECA (CF102) 6.66
6.55 (r)
5.27
6.33 (r)
<5 8.85
9.48 (r)
11 thio-Cl-IB-MECA 6.71 6.63 ND 9.42
12 MRS5698 <5 <5 <5 8.5
Adenosine receptor antagonists
Non-selective
13 Caffeine 4.97
4.39 (r)
5.02
4.32 (r)
4.98
4.52 (r)
4.88
<4 (r)
14 Theophylline 5.17
5.06 (r)
5.17
25,300 (r)
5.04
4.82 (r)
4.65
4.07 (r)
15 CGS15943 8.46
8.19 (r)
8.92 7.49 7.46
16 XAC 7.54
8.92 (r)
9.0
7.20 (r)
7.91 7.04
A1-selective
17 DPCPX (CPX) 8.52
9.0 (r)
7.22
6.30 (r)
7.29
6.73 (r)
6.61
4.37 (r)
18 PSB-36 9.2
9.91 (r)
6.01
6.26 (r)
6.73 5.64
5.19 (r)
A2A-selective
19 KW6002 6.08b
6.64(r)b
7.92
8.66 (r)
<5b 5.35b
20 CSCd 4.55 (r) 7.27 (r) 5.09 <5 (r)
21 ZM241,385 6.11 8.80 7.12 6.13
22 SCH442,416 5.95 8.39 <5 <5
A2B-selective
23 MRS1754 6.39
7.77 (r)
6.30
6.21 (r)
8.70
7.89 (r)
6.24
24 MRS1706 6.80 6.91 8.86 6.64
25 MRE2029-F20 6.70 <6 8.26 <6
26 PSB-603 <5
<5 (r)
<5
<5 (r)
9.26 <5
27 PSB-1115 <5
5.66 (r)
4.62 (r) 7.27 <5
A3-selective
28 MRS1523 <5
4.81 (r)
5.44
5.69 (r)
<5 7.72
6.95 (r)
29 PSB-10 5.77
6.09 (r)
5.57
5.22 (r)
ND 9.36
30 VUF5574 ≤5 (r) ≤5 (r) ND 8.39
31 MRS1191 <5
4.40 (r)
<5
<5 (r)
<5 7.50
5.73 (r)
32 MRS1334 <5 (r) <5 (r) ND 8.57
a

Data from binding assays, unless noted (for more details see 211 and references cited therein). Human, unless noted; r = rat.

b

From functional studies

c

ND = no data available

d

Ki at monoamine oxidase-B = 80.6 nM 226